In 2023, the mortality rate for trachea, bronchus, or lung malignant neoplasms among women in Japan stood at 36.5 per hundred thousand. The forecasted data indicates a gradual increase in mortality over the next five years, with a noticeable year-on-year rise of approximately 1.37% by 2028, reaching 38.4. This upward trend emphasizes a consistent growth pattern in female deaths due to these neoplasms, stressing the need for more intensive public health strategies and early intervention methodologies to alter this trajectory.
Future trends to watch for include advancements in medical technology and early detection methods, shifts in smoking prevalence, and the potential impact of air quality improvements or deteriorations, which may influence the actual mortality figures relative to these forecasts.
